Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2030

Conditions
Gastric Cancer
Interventions
OTHER

Surveillance

Close monitoring for disease recurrence.

DRUG

Adjuvant Chemotherapy

The adjuvant chemotherapy regimen will be standardized based on current clinical guidelines and may include combinations of agents such as fluoropyrimidines and oxaliplatin with or without docetaxel. Treatment until the progression of the process is detected or the maximum effect of therapy is achieved (the maximum duration of treatment is 3 months).

All Listed Sponsors
lead

Nizhny Novgorod Regional Clinical Oncology Center

OTHER_GOV